ranolazine has been researched along with adenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bairey Merz, CN; Berman, DS; Gill, E; Goykhman, P; Mehta, PK; Minissian, M; Shaw, LJ; Shufelt, C; Slivka, M; Slomka, PJ; Thomson, LE; Wei, J; Yang, Y | 1 |
1 review(s) available for ranolazine and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ranolazine and adenosine
| Article | Year |
|---|---|
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Topics: Acetanilides; Adenosine; Aged; Cardiovascular Agents; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Feasibility Studies; Female; Humans; Los Angeles; Magnetic Resonance Imaging; Microvascular Angina; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Pilot Projects; Piperazines; Placebo Effect; Quality of Life; Ranolazine; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vasodilator Agents | 2011 |